Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Lacinda Rishel

Physician Assistant Morehead, KY Physician Assistant

NPI 1619286739 CMS profile 10855152

1350 Flemingsburg Rd, Morehead, KY 40351

Open in the dashboard

General payments

$272

15 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Lacinda Rishel of Morehead, KY is reported in the CMS Open Payments database as having received $272 across 15 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 44th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $62 3
2024 General $31 2
2023 General $45 2
2022 General $47 3
2021 General $86 5

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Lacinda Rishel
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Lacinda Rishel were reported at $62. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Lacinda Rishel Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $86 $132 $37–$438 $132
2022 $47 $155 $48–$522 $149
2023 $45 $167 $52–$557 $160
2024 $31 $178 $55–$600 $164
2025 $62 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Orthofix Medical, Inc. $50 3 payments
  2. Flexion Therapeutics, Inc. $40 2 payments
  3. Pacira Pharmaceuticals Incorporated $34 2 payments
  4. Ferring Pharmaceuticals Inc. $31 1 payment
  5. Davol Inc. $25 1 payment
  6. Solventum Corporation $19 1 payment
  7. Zimmer Biomet Holdings, Inc. $17 1 payment
  8. SPR Therapeutics, Inc $16 1 payment
  9. Horizon Therapeutics plc $14 1 payment
  10. Endo Pharmaceuticals Inc. $13 1 payment
  11. Other $12 1 payment

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $272 15 payments
Products named General payments · program years 2021–2025
  1. Physio-Stim $65 4 payments
  2. Zilretta $40 2 payments
  3. EUFLEXXA $31 1 payment
  4. ARISTA $25 1 payment
  5. Exparel $19 1 payment
  6. PREVENA $19 1 payment
  7. V.A.C. VERAFLO $19 1 payment
  8. V.A.C.ULTA $19 1 payment
  9. Gel-One Cross-linked Hyaluronate $17 1 payment
  10. JuggerStitch $17 1 payment
  11. Other $71 5 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 10 drugs

Part D claims

739

Median for Physician Assistant: 241

Drug cost

$10,523

Median for Physician Assistant: $4,110

Branded share of claims

4.5%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Diclofenac Sodium Generic 84 $3,626
Celecoxib Generic 77 $2,324
Diclofenac Sodium-Misoprostol Diclofenac Sodium/Misoprostol Brand 13 $1,312
Prednisone Generic 105 $1,066
Cefadroxil Generic 40 $545
Meloxicam Generic 229 $472
Ibuprofen Generic 68 $460
Naproxen Generic 65 $406
Methylprednisolone Generic 38 $242
Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim Brand 20 $72

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 41 billing codes

Paid by Medicare

$95,176

Of which drugs: $43,700

Medicare patients

241

Average age 73

Services billed

27,243

155 women, 86 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 35%
Ischemic heart disease 29%
Depression 22%
COPD 20%
Chronic kidney disease 18%
Atrial fibrillation 14%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose J7324 Office 38 230 $22,096
Injection, methylprednisolone acetate, 1 mg J1010 Office 131 25,241 $2,539
Injection, methylprednisolone acetate, 80 mg J1040 Office 63 92 $423
Injection, methylprednisolone acetate, 40 mg J1030 Office 30 40 $91

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

15 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Kentucky

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record